Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.23 USD | -1.23% |
|
-1.75% | -19.67% |
06-27 | Dynavax Reports First Participant Dosed in Shingles Vaccine Trial | MT |
06-27 | Dynavax Technologies Corporation Initiates Phase 1/2 Study of Novel Shingles Vaccine Program | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.47B | ||||||
121B | ||||||
113B | ||||||
26.02B | - | |||||
19.39B | - | |||||
15.91B |